27 July 2017 - Seventy-five women are diagnosed with ovarian cancer in Saskatchewan each year, and fifty-five lose their lives. ...
4 July 2017 - Multiple myeloma, commonly referred to as myeloma, is an incurable cancer of the plasma cells found in ...
7 June 2017 - The Canadian Cancer Survivor Network and Lung Cancer Canada are calling on government and industry to ...
2 June 2017 - The Canadian pERC has recommended the funding of obinutuzumab (Gazyva) for use by adults with non-Hodgkin's ...
8 May 2017 - AstraZeneca is committed to rapid and collaborative discussions with pan-Canadian Pharmaceutical Alliance and provinces to get ...
1 May 2017 - The assessment of new cancer drugs in Canada increasingly engages specialist oncology physicians. This has not always ...
26 April 2017 - Jennifer McGrady has never even touched a cigarette. ...
30 March 2017 - The outcome relates to the use of obinutuzumab in combination with chemotherapy followed by obinutuzumab monotherapy ...
30 March 2017 - The recommendation relates to the use of vandetanib for the treatment of symptomatic and/or progressive medullary ...
30 March 2017 - The outcome relates to the use of carfilzomib in combination with dexamethasone by patients with relapsed ...
28 March 2017 - Roche was seeking a positive CADTH recommendation for the use of bevacizumab in combination with pemetrexed ...
6 March 2017 - Interesting insights from the pCODR Initial Economic Guidance Report for alectinib hydrochloide (Alecensaro). ...
7 March 2017 - A cancer patient who was told last week that she may not receive her much-needed chemotherapy ...
3 March 2016 - The outcome for three medicines, ceritinib (Zykadia), osimertinib mesylate (Tagrisso) and alectinib hydrochloride (Alecensaro), demonstrate the ...
10 January 2017 - Abbvie was seeking funding for venetoclax when used as a treatment for patients with chronic lymphocytic ...